Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
64.23
+0.10 (0.16%)
At close: Mar 9, 2026, 4:00 PM EDT
64.23
0.00 (0.00%)
After-hours: Mar 9, 2026, 7:00 PM EDT
Haemonetics Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | 2020 - 2016 |
| Market Capitalization | 2,985 | 3,175 | 4,335 | 4,175 | 3,263 | 5,694 | Upgrade
|
| Market Cap Growth | -6.36% | -26.76% | 3.83% | 27.92% | -42.69% | 12.14% | Upgrade
|
| Enterprise Value | 3,855 | 4,145 | 5,011 | 4,717 | 3,809 | 5,827 | Upgrade
|
| Last Close Price | 64.13 | 63.19 | 85.35 | 82.75 | 63.85 | 112.04 | Upgrade
|
| PE Ratio | 17.59 | 18.93 | 36.87 | 36.17 | 75.24 | 71.65 | Upgrade
|
| Forward PE | 12.43 | 13.21 | 20.49 | 25.45 | 23.82 | 33.88 | Upgrade
|
| PS Ratio | 2.27 | 2.33 | 3.31 | 3.57 | 3.29 | 6.54 | Upgrade
|
| PB Ratio | 3.29 | 3.87 | 4.51 | 5.10 | 4.36 | 7.78 | Upgrade
|
| P/TBV Ratio | - | - | - | 54.93 | - | - | Upgrade
|
| P/FCF Ratio | 9.72 | 22.29 | 30.18 | 51.08 | 43.08 | 79.34 | Upgrade
|
| P/OCF Ratio | 8.84 | 17.47 | 23.85 | 15.29 | 18.95 | 52.33 | Upgrade
|
| PEG Ratio | 1.13 | 1.00 | 1.39 | 2.42 | 1.36 | 2.46 | Upgrade
|
| EV/Sales Ratio | 2.92 | 3.05 | 3.83 | 4.04 | 3.84 | 6.69 | Upgrade
|
| EV/EBITDA Ratio | 10.56 | 11.65 | 16.96 | 18.72 | 19.87 | 31.60 | Upgrade
|
| EV/EBIT Ratio | 14.88 | 16.78 | 24.23 | 28.21 | 36.22 | 58.21 | Upgrade
|
| EV/FCF Ratio | 12.51 | 29.10 | 34.89 | 57.71 | 50.28 | 81.19 | Upgrade
|
| Debt / Equity Ratio | 1.34 | 1.56 | 0.91 | 1.02 | 1.12 | 1.08 | Upgrade
|
| Debt / EBITDA Ratio | 3.36 | 3.49 | 2.86 | 3.28 | 4.14 | 4.02 | Upgrade
|
| Debt / FCF Ratio | 3.98 | 9.01 | 6.08 | 10.16 | 11.07 | 10.98 | Upgrade
|
| Net Debt / Equity Ratio | 0.95 | 1.19 | 0.72 | 0.67 | 0.77 | 0.81 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.36 | 2.74 | 2.35 | 2.16 | 3.02 | 3.23 | Upgrade
|
| Net Debt / FCF Ratio | 2.80 | 6.85 | 4.83 | 6.67 | 7.64 | 8.30 | Upgrade
|
| Asset Turnover | 0.53 | 0.59 | 0.63 | 0.62 | 0.54 | 0.56 | Upgrade
|
| Inventory Turnover | 1.54 | 1.71 | 2.07 | 1.98 | 1.50 | 1.49 | Upgrade
|
| Quick Ratio | 1.04 | 0.88 | 1.29 | 1.85 | 0.95 | 1.26 | Upgrade
|
| Current Ratio | 1.75 | 1.62 | 2.56 | 3.06 | 1.71 | 2.74 | Upgrade
|
| Return on Equity (ROE) | 19.30% | 18.83% | 13.22% | 14.72% | 5.86% | 12.05% | Upgrade
|
| Return on Assets (ROA) | 6.45% | 6.65% | 6.26% | 5.51% | 3.57% | 4.05% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.27% | 11.33% | 10.62% | 10.14% | 5.40% | 8.96% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.30% | 13.20% | 10.90% | 9.90% | 7.40% | 6.40% | Upgrade
|
| Earnings Yield | 5.86% | 5.28% | 2.71% | 2.76% | 1.33% | 1.40% | Upgrade
|
| FCF Yield | 10.29% | 4.49% | 3.31% | 1.96% | 2.32% | 1.26% | Upgrade
|
| Buyback Yield / Dilution | 6.04% | 1.30% | 0.04% | -0.13% | -0.12% | 1.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.